Pharma-Bio Serv (PBSV) Operating Income Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 31.18% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 33.06% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 64.37% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | -8.90% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 31.04% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 3.40% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 39.83% |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -31.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -31.76% |
| Oct 31, 2025 | -40.76% |
| Jul 31, 2025 | -41.77% |
| Apr 30, 2025 | -32.96% |
| Jan 31, 2025 | -31.21% |
| Oct 31, 2024 | 68.21% |
| Jul 31, 2024 | -45.17% |
| Apr 30, 2024 | -47.11% |
| Jan 31, 2024 | -49.98% |
| Oct 31, 2023 | -32.78% |
| Jul 31, 2023 | -17.39% |
| Apr 30, 2023 | -19.20% |
| Jan 31, 2023 | -15.09% |
| Oct 31, 2022 | -26.56% |
| Jul 31, 2022 | 0.81% |
| Apr 30, 2022 | -16.20% |
| Jan 31, 2022 | -8.92% |
| Oct 31, 2021 | -126.67% |
| Jul 31, 2021 | -20.66% |
| Apr 30, 2021 | 219.11% |
| Jan 31, 2021 | 28.65% |
| Oct 31, 2020 | 6.67% |
| Jul 31, 2020 | 83.75% |
| Apr 30, 2020 | 61.59% |
| Jan 31, 2020 | 50.34% |
| Oct 31, 2019 | 43.39% |
| Jul 31, 2019 | 70.84% |
| Apr 30, 2019 | 71.45% |
| Jan 31, 2019 | 7.03% |
| Oct 31, 2018 | -4.19% |
| Jul 31, 2018 | 13.37% |
| Apr 30, 2016 | -62.17% |
| Jan 31, 2016 | -33.23% |
| Oct 31, 2015 | -25.60% |
| Jul 31, 2015 | -31.96% |